Fiduciary Trust’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-38,595
Closed -$3.83M 531
2019
Q3
$3.83M Buy
38,595
+6,664
+21% +$633K 0.1% 143
2019
Q2
$2.95M Buy
31,931
+3,133
+11% +$298K 0.08% 162
2019
Q1
$2.72M Buy
28,798
+424
+1% +$37.1K 0.07% 170
2018
Q4
$1.82M Sell
28,374
-1,526
-5% -$113K 0.06% 189
2018
Q3
$2.68M Buy
29,900
+6,103
+26% +$539K 0.08% 170
2018
Q2
$1.89M Sell
23,797
-2,639
-10% -$219K 0.06% 199
2018
Q1
$2.36M Buy
26,436
+382
+1% +$36.7K 0.07% 176
2017
Q4
$2.72M Sell
26,054
-2,947
-10% -$333K 0.08% 165
2017
Q3
$4.23M Sell
29,001
-138
-0.5% -$18.8K 0.13% 131
2017
Q2
$3.78M Buy
29,139
+1,834
+7% +$225K 0.12% 133
2017
Q1
$3.4M Sell
27,305
-1,635
-6% -$196K 0.1% 142
2016
Q4
$3.35M Buy
28,940
+3,877
+15% +$432K 0.11% 148
2016
Q3
$2.62M Sell
25,063
-17
-0.1% -$1.84K 0.09% 168
2016
Q2
$2.47M Buy
25,080
+1,082
+5% +$112K 0.09% 168
2016
Q1
$2.4M Sell
23,998
-23
-0.1% -$2.37K 0.08% 172
2015
Q4
$2.88M Buy
24,021
+143
+0.6% +$16.5K 0.12% 141
2015
Q3
$2.58M Sell
23,878
-71
-0.3% -$8.81K 0.12% 143
2015
Q2
$2.77M Buy
23,949
+87
+0.4% +$9.95K 0.12% 144
2015
Q1
$2.75M Buy
23,862
+272
+1% +$32.5K 0.11% 143
2014
Q4
$2.64M Buy
23,590
+1,804
+8% +$190K 0.11% 141
2014
Q3
$2.06M Buy
21,786
+556
+3% +$50.2K 0.09% 147
2014
Q2
$1.82M Buy
21,230
+10,390
+96% +$790K 0.08% 158
2014
Q1
$757K Buy
10,840
+1,000
+10% +$79.2K 0.03% 204
2013
Q4
$832K Sell
9,840
-1,400
-12% -$111K 0.04% 190
2013
Q3
$867K Buy
11,240
+400
+4% +$28K 0.04% 179
2013
Q2
$634K Buy
+10,840
New +$652K 0.03% 198

Other funds holding CELG

Fiduciary Trust's CELG Position: Q4 2019 in Review

Fiduciary Trust sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 38,595 shares — an estimated $3.83M sold.

Fiduciary Trust first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $4.23M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Fiduciary Trust reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Fiduciary Trust sold 38,595 Celgene Corp shares in Q4 2019, an estimated $3.83M.
  • Fiduciary Trust first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Fiduciary Trust's Celgene Corp position peaked at $4.23M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Fiduciary Trust's 13F filing for Q4 2019, filed 4 Feb 2020.